The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BackgroundThe gene expression classifier (GEC; Afirma–Veracyte) has proven to be an effective triage modality in the management of thyroid nodules. We evaluate our institutional experience with GEC, specifically examining performance as a first line testing strategy versus in conjunction with repeat fine needle aspiration (FNA), usage trends based on clinical setting, and performance related to diagnostic...
BACKGROUNDFine‐needle aspiration (FNA) biopsy is the most frequently used method for thyroid nodule evaluation. However, up to 30% of cases are considered indeterminate. Surgery is typically recommended for these cases, but up to two‐thirds of indeterminate cases are found to be benign. The Afirma test is used for the preoperative classification of thyroid nodules with indeterminate cytology. This...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.